1. Home
  2. OCSL vs AMPH Comparison

OCSL vs AMPH Comparison

Compare OCSL & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCSL
  • AMPH
  • Stock Information
  • Founded
  • OCSL 2007
  • AMPH 1996
  • Country
  • OCSL United States
  • AMPH United States
  • Employees
  • OCSL N/A
  • AMPH N/A
  • Industry
  • OCSL Finance: Consumer Services
  • AMPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • OCSL Finance
  • AMPH Health Care
  • Exchange
  • OCSL Nasdaq
  • AMPH Nasdaq
  • Market Cap
  • OCSL 1.1B
  • AMPH 1.2B
  • IPO Year
  • OCSL 2008
  • AMPH 2014
  • Fundamental
  • Price
  • OCSL $13.54
  • AMPH $24.32
  • Analyst Decision
  • OCSL Hold
  • AMPH Buy
  • Analyst Count
  • OCSL 6
  • AMPH 6
  • Target Price
  • OCSL $15.20
  • AMPH $35.50
  • AVG Volume (30 Days)
  • OCSL 871.3K
  • AMPH 397.5K
  • Earning Date
  • OCSL 11-18-2025
  • AMPH 11-06-2025
  • Dividend Yield
  • OCSL 11.62%
  • AMPH N/A
  • EPS Growth
  • OCSL N/A
  • AMPH N/A
  • EPS
  • OCSL 0.55
  • AMPH 2.68
  • Revenue
  • OCSL $334,099,000.00
  • AMPH $722,679,000.00
  • Revenue This Year
  • OCSL N/A
  • AMPH $0.74
  • Revenue Next Year
  • OCSL N/A
  • AMPH $5.63
  • P/E Ratio
  • OCSL $25.19
  • AMPH $9.04
  • Revenue Growth
  • OCSL N/A
  • AMPH 1.37
  • 52 Week Low
  • OCSL $12.44
  • AMPH $20.39
  • 52 Week High
  • OCSL $16.53
  • AMPH $53.96
  • Technical
  • Relative Strength Index (RSI)
  • OCSL 49.00
  • AMPH 42.56
  • Support Level
  • OCSL $13.49
  • AMPH $23.77
  • Resistance Level
  • OCSL $14.05
  • AMPH $25.65
  • Average True Range (ATR)
  • OCSL 0.25
  • AMPH 0.75
  • MACD
  • OCSL -0.02
  • AMPH 0.20
  • Stochastic Oscillator
  • OCSL 37.52
  • AMPH 31.13

About OCSL Oaktree Specialty Lending Corporation

Oaktree Specialty Lending Corp is a specialty finance company. The company provides lending services and invests in small and mid-sized companies. The company's investment objective is to maximize its portfolio's total return by generating current income from debt investments, and to a lesser extent, capital appreciation from equity investments. The company provides customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: